| scholarly article | Q13442814 |
| P50 | author | Susana Esteban | Q42761568 |
| P2093 | author name string | J A García-Sevilla | |
| J Manzanares | |||
| O Valverde | |||
| M S García-Gutiérrez | |||
| M Alvaro-Bartolomé | |||
| P2860 | cites work | FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis | Q24307362 |
| The Fas-FADD death domain complex structure unravels signalling by receptor clustering | Q24312945 | ||
| Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI. | Q24643957 | ||
| Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons | Q28144567 | ||
| Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities | Q28265029 | ||
| Cannabinoid signalling | Q28267949 | ||
| Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers | Q28296007 | ||
| Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain | Q28363748 | ||
| Tetrahydrocannabinol‐induced neurotoxicity depends on CB1 receptor‐mediated c‐Jun N‐terminal kinase activation in cultured cortical neurons | Q28565561 | ||
| Effect of cocaine on Fas-associated protein with death domain in the rat brain: individual differences in a model of differential vulnerability to drug abuse | Q28574580 | ||
| Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (FADD) protein in the rat brain: functional interactions with casein kinase Ialpha, Galpha(i) proteins, and ERK1/2 signaling | Q28575106 | ||
| The time course of unconditioned morphine-induced psychomotor sensitization mirrors the phosphorylation of FADD and MEK/ERK in rat striatum: role of PEA-15 as a FADD-ERK binding partner in striatal plasticity | Q28580593 | ||
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain | Q30047898 | ||
| Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of bcl-xL gene expression | Q33239704 | ||
| Mechanisms of control of neuron survival by the endocannabinoid system | Q33368214 | ||
| CB2 receptor ligands | Q33988721 | ||
| Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins | Q34306079 | ||
| Inverse agonism and neutral antagonism at cannabinoid CB1 receptors | Q34388049 | ||
| Pharmacology of cannabinoid CB1 and CB2 receptors. | Q34442847 | ||
| Cannabinoids and cell fate. | Q34786842 | ||
| In vivo cellular and molecular mechanisms of neuronal apoptosis in the mammalian CNS. | Q35145656 | ||
| The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis | Q35204851 | ||
| Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids | Q35672460 | ||
| FADD and its phosphorylation | Q35951072 | ||
| Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice. | Q36441179 | ||
| Caspase function in programmed cell death | Q36643566 | ||
| WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. | Q37371387 | ||
| Mitochondrial membrane permeabilization in neuronal injury | Q37526353 | ||
| Molecular ordering of the initial signaling events of CD95. | Q39676008 | ||
| Role of delta-opioid receptor function in neurogenesis and neuroprotection | Q40280641 | ||
| Constitutive endocytic cycle of the CB1 cannabinoid receptor. | Q40542809 | ||
| Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors | Q42525438 | ||
| Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence | Q42625437 | ||
| Biphasic effects of anandamide | Q43332781 | ||
| Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor | Q43503403 | ||
| Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages | Q43681018 | ||
| Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. | Q43734938 | ||
| Effects of constitutive deletion of opioid receptors on the basal densities of Fas and Fas-associated protein with death domain (FADD) in the mouse brain: a delta-opioid tone inhibits FADD. | Q44332344 | ||
| Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice | Q44350888 | ||
| Phosphorylation of FADD (Fas-associated death domain protein) at serine 194 is increased in the prefrontal cortex of opiate abusers: relation to mitogen activated protein kinase, phosphoprotein enriched in astrocytes of 15 kDa, and Akt signaling pat | Q46079632 | ||
| Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: compound-specific and area-specific distribution within the brain | Q46079782 | ||
| Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway. | Q46947457 | ||
| A comparison of the apoptotic effect of Delta(9)-tetrahydrocannabinol in the neonatal and adult rat cerebral cortex | Q46990151 | ||
| Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice | Q47994629 | ||
| Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. | Q48028956 | ||
| The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis | Q48143381 | ||
| Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. | Q48176645 | ||
| Acute, chronic and withdrawal effects of the cannabinoid receptor agonist WIN55212-2 on the sequential activation of MAPK/Raf-MEK-ERK signaling in the rat cerebral frontal cortex: short-term regulation by intrinsic and extrinsic pathways | Q48350845 | ||
| CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. | Q50891805 | ||
| Guide to Receptors and Channels (GRAC), 4th Edition | Q56639335 | ||
| Direct Quantitation of Poly(ADP-Ribose) Polymerase (PARP) Activity as a Means to Distinguish Necrotic and Apoptotic Death in Cell and Tissue Samples | Q61651216 | ||
| Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A | Q71152696 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| apoptotic process | Q14599311 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 643-656 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Regulation of Fas receptor/Fas-associated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain | |
| P478 | volume | 160 |
| Q34163269 | Cholecystokinin octapeptide antagonizes apoptosis in human retinal pigment epithelial cells |
| Q45851009 | Chronic treatment with selective I2-imidazoline receptor ligands decreases the content of pro-apoptotic markers in rat brain |
| Q38527077 | Decreased proliferation of adult hippocampal stem cells during cocaine withdrawal: possible role of the cell fate regulator FADD. |
| Q38593120 | Genetic Manipulation of the Endocannabinoid System |
| Q52646112 | Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex. |
| Q48337573 | Regulation of cannabinoid CB2 receptor constitutive activity in vivo: repeated treatments with inverse agonists reverse the acute activation of JNK and associated apoptotic signaling in mouse brain |
| Q47742909 | Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies? |
| Q36127141 | The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α. |
Search more.